| Date |
Research Question / Title |
Unique ID |
Research Team |
|
November 19, 2021
|
What is the epidemiology of variants and what are the implications for healthcare?
|
EOC031801v018 ESR
|
EOC
|
|
November 12, 2021
|
How effective are COVID-19 vaccines?
|
INF031801v017 ESR
|
Infectious Disease
|
|
November 5, 2021
|
What is the epidemiology of variants and what are the implications for healthcare?
|
EOC031801v017 ESR
|
EOC
|
|
October 21, 2021
|
Long COVID: What does it mean for the healthcare system and programs to deal with it?
|
EOC021901v2 ESR
|
EOC
|
|
October 4, 2021
|
What have been the consequences of delayed surgeries due to the COVID-19 pandemic?
|
EOC210903 ESR
|
EOC
|
|
September 29, 2021
|
What is the current evidence and recommendations regarding COVID-19 vaccine booster shots (exceeding 2 doses) for the general population?
|
EOC210902 ESR
|
EOC
|
|
August 17, 2021
|
What are other jurisdictions offering for incentive-based COVID-19 vaccine campaigns?
|
EOC210501v2 ESR
|
EOC
|
|
July 16, 2021
|
What is known about safety/efficacy of global vaccines not approved in Canada? What are the impacts on international travel and vaccination policies?
|
INF210701 ESR
|
Infectious Disease
|
|
June 25, 2021
|
What is the incidence and duration of long COVID cases?
|
EPM210601 ESR
|
Epidemiology & Modelling
|
|
June 25, 2021
|
What are long COVID's demands on the healthcare system, and its
severity of the illness?
|
EPM210602 ESR
|
Epidemiology & Modelling
|
|
June 2, 2021
|
What are legitimate exemptions/contraindications for COVID-19 vaccines from a medical point of view?
|
EOC210502 ESR
|
EOC
|
|
June 1, 2021
|
What are the ethical/legal aspects of vaccine requirements?
|
EOC210503 ESR
|
EOC
|
|
April 1, 2021
|
What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations?
|
EOC210302 ESR
|
EOC
|
|
March 31, 2021
|
How to deliver remote ICU care for COVID-19 patients to avoid/prevent transfer from smaller communities to tertiary care hospitals
|
CC210301 ESR
|
Critical Care
|
|
March 11, 2021
|
What are the differences between COVID-19 vaccines and how should they be distributed based on population group(s)?
|
EOC031001-01 ESR
|
EOC
|
|
March 4, 2021
|
What are the vaccination strategies for vulnerable populations?
|
PH030401-01 ESR
|
Public Health
|
|
February 22, 2021
|
What is the epidemiology of variants and what are the implications for healthcare?
|
EOC022201-01 ESR
|
EOC
|
|
January 27, 2021
|
What is the risk of transmission of COVID-19 from high respiratory efforts for prolonged periods of time (>15 min) at a physical distance of 3-4 m or more?
|
PH012501-02 ESR
|
Public Health
|
|
January 26, 2021
|
What is the risk of transmission of COVID-19 from high respiratory efforts for prolonged periods of time (>15 min) at a physical distance of 3-4 m or more?
|
PH012501-01 ESR
|
Public Health
|
|
January 19, 2021
|
What is the final disposition of post-COVID patients who require chronic ventilation in the ICU?
|
CC011101-01 ESR
|
Critical Care
|
